Frank Holler has joined the board of directors for Genome British Columbia. Holler is currently CEO and fund manager for BC Advantage Funds and has been a prominent executive for several biotechnology firms and has extensive experience in the banking industry. He was president and CEO of both ID Biomedical Corp and Zenon Genetics Inc (now Xenon Pharmaceuticals Inc) and a founding director of Angiotech Pharmaceuticals. He holds an MBA and BA in economics from the Univ of British Columbia….